FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123167457> ?p ?o ?g. }

• W2123167457 endingPage "1015" @default.
• W2123167457 startingPage "1006" @default.
• W2123167457 abstract "In Germany, the clinical use of TNF-α inhibitors in the therapy of rheumatoid arthritis (RA) grew from 2 % of treated patients in 2000 to 20 % in 2008. In 2012, adalimumab was the bestselling drug in the statutory health insurance system with net expenditure of € 581 mio. We aim to analyze the cost-effectiveness of adalimumab for the treatment of RA in Germany. We set up an individual patient sampling lifetime model to simulate 10,000 hypothetical patients. The patients’ functional status improves according to American College of Rheumatology response criteria. In each 6‑month cycle, treatment might be discontinued due to loss of efficacy or adverse events. In the base case, patients gain 7.07 quality-adjusted life years (QALYs) with conventional synthetic therapy and 9.92 QALYs if adalimumab combination therapy is added to the treatment algorithm. The incremental cost-utility ratio (ICUR) is € 24,492 based on German list prices. After deducting mandatory rebates and taxes, the ICUR is € 17,277, comparing favorably to analyses in other countries. Adalimumab combination therapy lowers indirect costs from € 162,698 to € 134,363. The ICUR based on total costs is € 14,550 (€ 7,335 after deducting taxes and rebates). Sensitivity analysis shows that adalimumab combination therapy becomes a dominant treatment option for younger baseline populations, i. e. adalimumab is both more effective and less expensive for baseline age 30 due to savings in indirect costs. Our complex probabilistic model shows that estimation of cost-effectiveness for RA relies on the incorporation of indirect costs and a sufficiently long simulation horizon to capture the complete range of possible outcomes and the associated long-term benefits of biological treatment." @default.
• W2123167457 created "2016-06-24" @default.
• W2123167457 creator A5028288460 @default.
• W2123167457 creator A5060542405 @default.
• W2123167457 creator A5069618098 @default.
• W2123167457 date "2016-04-14" @default.
• W2123167457 modified "2023-09-26" @default.
• W2123167457 title "Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany" @default.
• W2123167457 cites W115413359 @default.
• W2123167457 cites W1526394947 @default.
• W2123167457 cites W1551184362 @default.
• W2123167457 cites W1562415841 @default.
• W2123167457 cites W1917667669 @default.
• W2123167457 cites W1974802441 @default.
• W2123167457 cites W1981122966 @default.
• W2123167457 cites W2002814457 @default.
• W2123167457 cites W2006464848 @default.
• W2123167457 cites W2014937111 @default.
• W2123167457 cites W2043951092 @default.
• W2123167457 cites W2090818138 @default.
• W2123167457 cites W2102987799 @default.
• W2123167457 cites W2109268320 @default.
• W2123167457 cites W2113633952 @default.
• W2123167457 cites W2114270885 @default.
• W2123167457 cites W2118378094 @default.
• W2123167457 cites W2118406374 @default.
• W2123167457 cites W2132473290 @default.
• W2123167457 cites W2134363311 @default.
• W2123167457 cites W2135644975 @default.
• W2123167457 cites W2162254515 @default.
• W2123167457 cites W2164024605 @default.
• W2123167457 cites W2320562573 @default.
• W2123167457 cites W2488671599 @default.
• W2123167457 cites W256864027 @default.
• W2123167457 cites W48282725 @default.
• W2123167457 doi "https://doi.org/10.1007/s00393-016-0071-9" @default.
• W2123167457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5127857" @default.
• W2123167457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27080399" @default.
• W2123167457 hasPublicationYear "2016" @default.
• W2123167457 type Work @default.
• W2123167457 sameAs 2123167457 @default.
• W2123167457 citedByCount "11" @default.
• W2123167457 countsByYear W21231674572017 @default.
• W2123167457 countsByYear W21231674572018 @default.
• W2123167457 countsByYear W21231674572019 @default.
• W2123167457 countsByYear W21231674572020 @default.
• W2123167457 countsByYear W21231674572021 @default.
• W2123167457 countsByYear W21231674572023 @default.
• W2123167457 crossrefType "journal-article" @default.
• W2123167457 hasAuthorship W2123167457A5028288460 @default.
• W2123167457 hasAuthorship W2123167457A5060542405 @default.
• W2123167457 hasAuthorship W2123167457A5069618098 @default.
• W2123167457 hasBestOaLocation W21231674571 @default.
• W2123167457 hasConcept C121955636 @default.
• W2123167457 hasConcept C126322002 @default.
• W2123167457 hasConcept C144133560 @default.
• W2123167457 hasConcept C197934379 @default.
• W2123167457 hasConcept C198451711 @default.
• W2123167457 hasConcept C2777575956 @default.
• W2123167457 hasConcept C2780132546 @default.
• W2123167457 hasConcept C6964187 @default.
• W2123167457 hasConcept C71924100 @default.
• W2123167457 hasConceptScore W2123167457C121955636 @default.
• W2123167457 hasConceptScore W2123167457C126322002 @default.
• W2123167457 hasConceptScore W2123167457C144133560 @default.
• W2123167457 hasConceptScore W2123167457C197934379 @default.
• W2123167457 hasConceptScore W2123167457C198451711 @default.
• W2123167457 hasConceptScore W2123167457C2777575956 @default.
• W2123167457 hasConceptScore W2123167457C2780132546 @default.
• W2123167457 hasConceptScore W2123167457C6964187 @default.
• W2123167457 hasConceptScore W2123167457C71924100 @default.
• W2123167457 hasIssue "10" @default.
• W2123167457 hasLocation W21231674571 @default.
• W2123167457 hasLocation W21231674572 @default.
• W2123167457 hasLocation W21231674573 @default.
• W2123167457 hasLocation W21231674574 @default.
• W2123167457 hasOpenAccess W2123167457 @default.
• W2123167457 hasPrimaryLocation W21231674571 @default.
• W2123167457 hasRelatedWork W2038008640 @default.
• W2123167457 hasRelatedWork W2108849668 @default.
• W2123167457 hasRelatedWork W2156283049 @default.
• W2123167457 hasRelatedWork W2162936925 @default.
• W2123167457 hasRelatedWork W2352867790 @default.
• W2123167457 hasRelatedWork W2783466784 @default.
• W2123167457 hasRelatedWork W2884735395 @default.
• W2123167457 hasRelatedWork W4253441873 @default.
• W2123167457 hasRelatedWork W4385356818 @default.
• W2123167457 hasRelatedWork W94518001 @default.
• W2123167457 hasVolume "75" @default.
• W2123167457 isParatext "false" @default.
• W2123167457 isRetracted "false" @default.
• W2123167457 magId "2123167457" @default.
• W2123167457 workType "article" @default.